Synapse - Works

Results (5608)

Enzalutamide (ENZA) in men with chemotherapy-Naive metastatic castration-resistant prostate cancer (mCRPC): Final analysis of the phase 3 PREVAIL study

Meeting Abstract

Beer, T. M.; Armstrong, A. J.; Sternberg, C. N.; Higano, C. S.; Rathkopf, D. E.; Loriot, Y.; Saad, F.; Joshua, A. M.; de Bono, J. S.; Venner, P. M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Employment and quality of life (QOL) in human papillomavirus-related (HPV+) oropharynx cancer treated with definitive chemoradiation (CTRT)

Meeting Abstract

Baxi, S. S.; Xiao, H.; Fury, M. G.; Atoria, C. L.; Dunn, L.; Salz, T.; Sherman, E. J.; Ho, A. L.; Lee, N. Y.; Pfister, D. G.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Using mutational load in next generation sequencing (NGS) to identify mismatch repair (MMR) deficiency in colorectal cancer (CRC)

Meeting Abstract

Battaglin, F.; Stadler, Z. K.; Cercek, A.; Yaeger, R. D.; Segal, N. H.; Varghese, A. M.; Kemeny, N. E.; Weiser, M. R.; Garcia-Aguilar, J.; Shia, J.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Association of somatic mutations in DNA damage repair (DDR) genes with efficacy of platinum-based chemotherapy in advanced urothelial carcinoma

Meeting Abstract

Bambury, R. M.; Jordan, E.; Zabor, E. C.; Bouvier, N.; Al-Ahmadie, H.; Boyd, M. E.; Mullane, S. A.; Cha, E. K.; Ostrovnaya, I.; Hyman, D. M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

KEYNOTE-052: Phase 2 study of pembrolizumab (MK-3475) as first-line therapy for patients (pts) with unresectable or metastatic urothelial cancer ineligible for cisplatin-based therapy

Meeting Abstract

Bajorin, D. F.; Plimack, E. R.; Siefker-Radtke, A. O.; Choueiri, T. K.; De Wit, R.; Sonpavde, G.; Gipson, A.; Brown, H.; Mai, Y. B.; Pang, L.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Chronic health conditions (CHCs) following cisplatin-based chemotherapy (CHEM): A multi-institutional study of 680 testicular cancer survivors (TCS)

Meeting Abstract

Abu Zaid, M. I.; Sesso, H. D.; Fung, C.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Beard, C.; Moore, M. J.; Sahasrabudhe, D. M.; Johnson, E.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay

Meeting Abstract

Abida, W.; Curtis, K. R.; Taylor, B. S.; Arcila, M. E.; Brennan, R.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Solit, D. B.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Salvage high-dose chemotherapy for germ cell tumors

Journal Article

Feldman, D. R.; Powles, T.
Urologic Oncology: Seminars and Original Investigations (2015)

Fulltext@MSK | Save

Late relapse of testicular germ cell tumors

Journal Article

O'Shaughnessy, M. J.; Feldman, D. R.; Carver, B. S.; Sheinfeld, J.
Urologic Clinics of North America (2015)

Fulltext@MSK | Save

Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 mutations characterize a subgroup of muscle-invasive bladder cancers with excellent response to neoadjuvant chemotherapy. Eur Urol. in press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

Journal Article

Van Allen, E. M.; Garraway, L. A.; Rosenberg, J. E.
European Urology (2015)

Fulltext@MSK | Save